STarting incrEmental Prescription of Peritoneal Dialysis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Queensland
About this trial
Kidney failure is fatal without dialysis. Peritoneal dialysis (PD) completed at home offers greater flexibility and autonomy for patients . However, PD is often prescribed for 24 hours/day, 7 days/week for every patient starting dialysis. This practice is not evidence-informed, may be unnecessary and potentially harmful. The STEP-PD trial aims to determine the optimal approach to commencing patients on PD through starting at low dose PD and incrementing over time.
Eligibility criteria
Qualifiers
adults (≥18 years) commencing PD as their first dialysis therapy (and been on dialysis for <1 month)
able to give informed consent
Disqualifiers
urine output <0.5L/day
previous kidney transplant
unlikely to be on dialysis for ≥1 year.
known or planned pregnancy during the trial
Trial design
Treatments tested in this trial
- Incremental PD
- Full dose PD
Treatment groups
224 Participants
are divided into 2 treatment groupsLocations
9Australia
Blacktown2148, BlacktownNew South Wales, Australia
Princess Alexandra Hospital4102, BrisbaneQueensland, Australia
Eastern Health3218, Box HillVictoria, Australia
New Zealand
Waitemata0610, Auckland New Zealand
Sponsors and collaborators
The University of Queensland
Lead sponsor
Source ClinicalTrials.gov